Clinical Trial Update: Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

View source ↗

Summary

The clinical trial investigating quantitation of endothelial progenitor cells as markers of tumor angiogenesis in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Breast Cancer Stage IV, Breast Cancer Stage I | Status: COMPLETED